Periodic Reporting for period 1 - PATGlycoPrint (Development of a new process analytical technology based on an innovative nanoplasmonic detection array for monitoring glycosylation of monoclonal antibodies)

During the production of biopharmaceuticals, monitoring and controlling critical quality attributes and process parameters is central to ensure that the products meet the regulatory requirements with respect to safety and quality and to facilitate efficient and cost-effective...